Proteolytic processing of chromogranin A by the prohormone convertase PC2

Regulatory Peptides

Volumn 111, Issue 1-3, 2003, Pages 111-116

  Doblinger, Alfred ^a   Becker, Alexandra ^a   Seidah, Nabil G ^b   Laslop, Andrea ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

(Neuro)peptides; Chromogranins; Neuroendocrine; Prohormone maturation; Proprotein convertase

Indexed keywords

CHROMOGRANIN A; FURIN; PEPTIDE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYMATIC DEGRADATION; GEL FILTRATION; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEUROBLASTOMA CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RNA EXTRACTION;

BLOTTING, NORTHERN; CHROMOGRANIN A; CHROMOGRANINS; CLONING, MOLECULAR; HUMANS; IMMUNOBLOTTING; NEOPLASM PROTEINS; NEUROBLASTOMA; PEPTIDE FRAGMENTS; PROPROTEIN CONVERTASE 2; PROTEIN PROCESSING, POST-TRANSLATIONAL; RADIOIMMUNOASSAY; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037471347     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00262-8     Document Type: Article

References (43)

1. Winkler H., Fischer-Colbrie R. The chromogranins A and B: the first 25 years and future perspectives. Neuroscience. 49:1992;497-528.
2. Iacangelo A.L., Eiden L.E. Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway. Regul. Pept. 58:1995;65-88.
3. Aunis D., Metz-Boutigue M.-H. Chromogranins: current concepts: structural and functional aspects. Helle K.B., Aunis D. Chromogranins: functional and clinical aspects. Adv. Exp. Med. Biol. vol. 482:2000;21-38 Kluwer Academic Publishing, New York.
4. Laslop A., Doblinger A., Weiss U. Proteolytic processing of chromogranins. Helle K.B., Aunis D. Chromogranins: functional and clinical aspects. Adv. Exp. Med. Biol. vol. 482:2000;155-166 Kluwer Academic Publishing, New York.
5. Helle K.B., Marley P.D., Hogue-Angeletti R., Aunis D., Galindo E., Small D.H.et al. Chromogranin A: secretion of processed products from the stimulated retrogradely perfused bovine adrenal gland. J. Neuroendocrinol. 5:1993;413-420.
6. Drees B.M., Rouse J., Johnson J., Hamilton J.W. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Endocrinology. 129:1991;3381-3387.
7. Aardal S., Helle K.B., Elsayed S., Reed R.K., Serck-Hanssen G. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J. Neuroendocrinol. 5:1993;405-412.
8. Lugardon K., Raffner R., Goumon Y., Corti A., Delmas A., Bulet P.et al. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J. Biol. Chem. 275:2000;10745-10753.
9. 347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocrinology. 133:1993;461-466.
10. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin: further evidence for its consideration as a regulatory peptide. J. Mol. Endocrinol. 16:1996;1-8.
11. Mahata S.K., O'Connor D.T., Mahata M., Yoo S.H., Taupenot L., Wu H.J.et al. Novel autocrine feedback control of catecholamine release - a discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J. Clin. Invest. 100:1997;1623-1633.
12. Kirchmair R., Leitner B., Fischer-Colbrie R., Marksteiner J., Hogue-Angeletti R., Winkler H. Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues. Biochem. J. 310:1995;331-336.
13. Seidah N.G., Chrétien M. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848:1999;45-62.
14. Arden S.D., Rutherford N.G., Guest P.C., Curry W.J., Bailyes E.M., Johnston C.F.et al. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. Biochem. J. 298:1994;521-528.
15. Eskeland N.L., Zhou A., Dinh T.Q., Wu H.J., Parmer R.J., Mains R.E.et al. Chromogranin A processing and secretion. Specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J. Clin. Invest. 98:1996;148-156.
16. Udupi V., Lee H.-M., Kurosky A., Greeley G.H. Jr. Prohormone convertase-1 is essential for conversion of chromogranin A to pancreastatin. Regul. Pept. 83:1999;123-127.
17. Laslop A., Weiss C., Savaria D., Eiter C., Tooze S.A., Seidah N.G.et al. Proteolytic processing of chromogranin B and secretogranin II by prohormone convertases. J. Neurochem. 70:1998;374-383.
18. Seidah N.G., Gaspar L., Mion P., Marcinkiewicz M., Mbikay M., Chrétien M. cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases. DNA Cell Biol. 9:1990;415-424.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
20. Weiss C., Winkler H., Laslop A. Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells. Neurochem. Int. 38:2001;43-52.
21. Day R., Schafer M.K.-H., Watson S.J., Chrétien M., Seidah N.G. Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol. Endocrinol. 6:1992;485-497.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Burnette W.N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:1981;195-203.
24. Kirchmair R., Gee P., Hogue-Angeletti R., Laslop A., Fischer-Colbrie R., Winkler H. Immunological characterization of the endoproteases PC1 and PC2 in adrenal chromaffin granules and in the pituitary gland. FEBS Lett. 297:1992;302-305.
25. Kroesen S., Marksteiner J., Leitner B., Hogue-Angeletti R., Fischer-Colbrie R., Winkler H. Rat brain: distribution of immunoreactivity of PE-11, a peptide derived from chromogranin B. Eur. J. Neurosci. 8:1996;2679-2689.
26. Iacangelo A., Affolter H.-U., Eiden L.E., Herbert E., Grimes M. Bovine chromogranin A sequence and distribution of its messenger RNA in endocrine tissues. Nature. 323:1986;82-86.
27. Benedum U.M., Baeuerle P.A., Konecki D.S., Frank R., Powell J., Mallet J.et al. The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells. EMBO J. 5:1986;1495-1502.
28. Helman L.J., Ahn T.G., Levine M.A., Allison A., Cohen P.S., Cooper M.J.et al. Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J. Biol. Chem. 263:1988;11559-11563.
29. Mouland A.J., Bevan S., White J.H., Hendy G.N. Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression. J. Biol. Chem. 269:1994;6918-6926.
30. Seidah N.G., Chrétien M., Day R. The family of subtilisin/kexin like pro-protein and pro-hormone convertases: divergent or shared functions. Biochimie. 76:1994;197-209.
31. O'Hare M.M.T., Schwartz T.W. Expression and precursor processing of neuropeptide Y in human and murine neuroblastoma and pheochromocytoma cell lines. Cancer Res. 49:1989;7015-7019.
32. Folkesson R., Monstein H.-J., Geijer T., Pahlman S., Nilsson K., Terenius L. Expression of the proenkephalin gene in human neuroblastoma cell lines. Mol. Brain Res. 3:1988;147-154.
33. Mbikay M., Seidah N.G., Chrétien M. Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem. J. 357:2001;329-342.
34. Dittié A.S., Tooze S.A. Characterization of the endopeptidase PC2 activity towards secretogranin II in stably transfected PC12 cells. Biochem. J. 310:1995;777-787.
35. Hoflehner J., Eder U., Laslop A., Seidah N.G., Fischer-Colbrie R., Winkler H. Processing of secretogranin II by prohormone convertases: importance of PC1 in generation of secretoneurin. FEBS Lett. 360:1995;294-298.
36. Benjannet S., Rondeau N., Day R., Chrétien M., Seidah N.G. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc. Natl. Acad. Sci. U. S. A. 88:1991;3564-3568.
37. Thomas L., Leduc R., Thorne B.A., Smeekens S.P., Steiner D.F., Thomas G. Kex-2 like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc. Natl. Acad. Sci. U. S. A. 88:1991;5297-5301.
38. Marcinkiewicz M., Ramla D., Seidah N.G., Chrétien M. Developmental expression of the prohormone convertases PC1 and PC2 in mouse pancreatic islets. Endocrinology. 135:1994;1651-1660.
39. Schmidt W.E., Siegel E.G., Lamberts R., Gallwitz B., Creutzfeldt W. Pancreastatin: molecular and immunocytochemical characterization of a novel peptide in porcine and human tissues. Endocrinology. 123:1988;1395-1404.
40. Kimura W., Jimi A., Miyasaka K., Tateishi K., Kuroda A., Morioka Y.et al. Immunohistochemical study of the distribution of pancreastatin in endocrine tumors of the pancreas and in normal pancreatic tissue: analysis of autopsy cases. Pancreas. 6:1991;688-693.
41. Jiang Q., Taupenot L., Mahata S.K., Mahata M., O'Connor D.T., Miles L.A.et al. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J. Biol. Chem. 276:2001;25022-25029.
42. Furuta M., Yano H., Zhou A., Rouillé Y., Holst J.J., Carroll R.et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc. Natl. Acad. Sci. U. S. A. 94:1997;6646-6651.
43. Furuta M., Carroll R., Martin S., Swift H.H., Ravazzola M., Orci L.et al. Incomplete processing of proinsulin to insulin accompanied by elevation of des-31, 32 proinsulin intermediates in islets of mice lacking active PC2. J. Biol. Chem. 273:1998;3431-3437.